Chair: T. Eschenhagen (Hamburg), J. Kockskämper (Marburg)
| (V833) | Nonsense mediated mRNA decay factor UPF3B is associated with cMyBP-C haploinsufficiency in hypertrophic cardiomyopathy patients with MYBPC3 truncation mutations | |
| V. Burkart, K. Kowalski, A. Zeug, D. Hilfiker-Kleiner, S. Lal, C. dos Remedios, A. Perrot, C. Ho, O. Dittrich-Breiholz, T. Kraft, J. Montag (Hannover, Marburg, Berlin; Sydney, AU; Boston, US) | ||
| Diskussion | ||
| (V834) | MicroRNAs for therapeutic modulation of contractile dysfunction in patient-specific iPSC-derived cardiomyocytes with hypertrophic cardiomyopathy | |
| K. Menge, J. Gruber, A. A. Derda, C. Jahn, M. Juchem, M. Fuchs, A. Gietz, A. Pfanne, I. Riedel, R. Zweigerdt, T. Kraft, A. Zeug, E. Ponimaskin, C. Bär, N. Weber, T. Thum, für die Studiengruppe: IMTTS (Hannover) | ||
| Diskussion | ||
| (V835) | STRIP1, a novel nucleolar located STRIPAK-member, regulates cardiac hypertrophy and is downregulated in human cardiomyopathy | |
| E. Heilein, M. Leye, S. T. Sossalla, B. Meder, N. Frey, M. Eden (Heidelberg, Kiel, Regensburg) | ||
| Diskussion | ||
| (V836) | Contractile imbalance in an early stage disease model for Hypertrophic Cardiomyopathy | |
| J. Montag, N. Weber, K. Kowalski, A.-K. Mayer, B. Iorga, A. Brunkhorst, R. Zweigerdt, J. Meißner, T. Kraft (Hannover) | ||
| Diskussion | ||
| (V837) | Creatine kinase disruption induces the production of mitochondrial reactive oxygen species - Implications for hypertrophic cardiomyopathy | |
| A. Xu, F. Stadler, D. Weissman, K. Ermer, M. Kohlhaas, C. Lygate, J. Van der Velden, N. Hamdani, C. Maack, V. Sequeira (Würzburg, Bochum; Oxford, UK; Amsterdam, NL) | ||
| Diskussion |
